... biopharmaceutical company's stock worth $5,712,000 after acquiring an additional 170,126 shares in the last quarter. Ardsley Advisory Partners raised its stake in CymaBay Therapeutics by 66.2% during the second quarter. Ardsley Advisory Partners now ...
https://sportsperspectives.com/2018/01/24/insider-selling-cymabay-therapeutics-inc-cbay-director-sells-138253-shares-of-stock.html
No comments:
Post a Comment